Recombinant Human RAD51D Protein ，GST

RAD51D is a crucial protein involved in the fundamental process of homologous recombination, a key mechanism for repairing DNA double-strand breaks and ensuring genomic stability. Mutations in the RAD51D gene have been linked to hereditary breast and ovarian cancer, particularly in families with a predisposition to these malignancies. This association highlights the protein's potential role as a tumor suppressor, as its dysfunction can lead to genomic instability and increased cancer risk. Researchers have focused on understanding the biochemical properties and molecular mechanisms of RAD51D, including its interactions with other repair proteins and its regulation during the DNA damage response. Recent studies employing advanced techniques such as cryo-electron microscopy and biochemical assays have revealed insights into the protein's structural dynamics and recruitment to sites of DNA damage. Furthermore, the characterization of RAD51D's role in DNA repair pathways has opened avenues for targeted therapies, especially in cancer types associated with RAD51D mutations. Understanding the implications of RAD51D function in both normal cellular processes and oncogenesis is critical for developing novel strategies in cancer prevention and treatment, making it a significant focus of ongoing genetic and therapeutic research in oncology.